Literature DB >> 35098443

Inducing substances for chondrogenic differentiation of dental pulp stem cells in the conditioned medium of a novel chordoma cell line.

Hiroyoshi Kino1, Hiroyoshi Akutsu2,3, Hiroshi Ishikawa4, Shingo Takano1, Shohei Takaoka5, Junko Toyomura4, Takuma Hara1, Eiichi Ishikawa1, Yuji Matsumaru1, Hiroki Bukawa5, Akira Matsumura1.   

Abstract

We successfully established a chordoma cell line, designated TSK-CHO1, derived from the clival chordoma. Currently, there is only one skull base chordoma cell line, UM-chor1, freely available to researchers. The established TSK-CHO1 cells were neoplastic, exhibited pleomorphic features, and secreted brachyury, as revealed by immunocytochemical staining or ELISA of conditioned medium (CM). Cells also secreted SOX9, which enhanced brachyury production. The CM of TSK-CHO1 cells promoted the production of hyaluronic acid and type II collagen during differentiation of human dental pulp stem cells (DPSCs) into fibrocartilage cells. Culture of DPSC pellets in a growth medium supplemented with 10% CM of TSK-CHO1 cells for 2 weeks resulted in the induction of fibrocartilage tissue under normoxic conditions. Brachyury produced by TSK-CHO1 cells promoted the production of collagen type II, peculiar to cartilage, in a dose-dependent manner. The newly established skull base chordoma cell line, TSK-CHO1, is expected to be used for elucidating the pathogenesis of skull base chordoma and for investigating the mechanism underlying the production of fibrocartilage.
© 2021. The Author(s) under exclusive licence to Japan Human Cell Society.

Entities:  

Keywords:  Brachyury; Chordoma cell line; Conditioned medium; Fibrocartilage; Skull base

Mesh:

Substances:

Year:  2022        PMID: 35098443     DOI: 10.1007/s13577-021-00662-5

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  28 in total

1.  Chordoma: incidence and survival patterns in the United States, 1973-1995.

Authors:  M L McMaster; A M Goldstein; C M Bromley; N Ishibe; D M Parry
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

2.  Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.

Authors:  Beate Rinner; Elke Verena Froehlich; Karin Buerger; Heike Knausz; Birgit Lohberger; Susanne Scheipl; Carina Fischer; Andreas Leithner; Christian Guelly; Slave Trajanoski; Karoly Szuhai; Bernadette Liegl
Journal:  Int J Oncol       Date:  2011-10-14       Impact factor: 5.650

3.  Proton beam therapy for skull base chordomas in 106 patients: A dose adaptive radiation protocol.

Authors:  Vivien Fung; Valentin Calugaru; Stéphanie Bolle; Hamid Mammar; Claire Alapetite; Philippe Maingon; Ludovic De Marzi; Sébastien Froelich; Jean-Louis Habrand; Rémi Dendale; Georges Noël; Loïc Feuvret
Journal:  Radiother Oncol       Date:  2018-01-06       Impact factor: 6.280

4.  Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal.

Authors:  Yasutaka Hayashi; Masashi Mizumoto; Hiroyoshi Akutsu; Shingo Takano; Akira Matsumura; Toshiyuki Okumura; Takuya Kawabe; Junko Zenkoh; Hideyuki Sakurai; Koji Tsuboi
Journal:  Br J Radiol       Date:  2016-04-21       Impact factor: 3.039

Review 5.  Chordomas: A Review.

Authors:  Bernard George; Damien Bresson; Philippe Herman; Sébastien Froelich
Journal:  Neurosurg Clin N Am       Date:  2015-07       Impact factor: 2.509

6.  Establishment and characterization of a novel chordoma cell line: CH22.

Authors:  Xianzhe Liu; Gunnlager Petur Nielsen; Andrew E Rosenberg; Peter R Waterman; Wen Yang; Edwin Choy; Slim Sassi; Shuhua Yang; David C Harmon; Cao Yang; Joseph H Schwab; Eisuke Kobayashi; Henry J Mankin; Ramnik Xavier; Ralph Weissleder; Zhenfeng Duan; Francis J Hornicek
Journal:  J Orthop Res       Date:  2012-04-13       Impact factor: 3.494

7.  Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.

Authors:  Wesley Hsu; Ahmed Mohyeldin; Sagar R Shah; Colette M ap Rhys; Lakesha F Johnson; Neda I Sedora-Roman; Thomas A Kosztowski; Ola A Awad; Edward F McCarthy; David M Loeb; Jean-Paul Wolinsky; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2011-06-24       Impact factor: 5.115

8.  Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population.

Authors:  Nicolas R Smoll; Oliver P Gautschi; Ivan Radovanovic; Karl Schaller; Damien C Weber
Journal:  Cancer       Date:  2013-03-15       Impact factor: 6.860

9.  Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results.

Authors:  Matthias Uhl; Matthias Mattke; Thomas Welzel; Falk Roeder; Jan Oelmann; Gregor Habl; Alexandra Jensen; Malte Ellerbrock; Oliver Jäkel; Thomas Haberer; Klaus Herfarth; Jürgen Debus
Journal:  Cancer       Date:  2014-06-19       Impact factor: 6.860

Review 10.  Chordoma: the entity.

Authors:  Youssef Yakkioui; Jacobus J van Overbeeke; Remco Santegoeds; Manon van Engeland; Yasin Temel
Journal:  Biochim Biophys Acta       Date:  2014-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.